The Mesothelioma Clinical Trial Digest
The Mesothelioma Clinical Trial Digest (“Meso Digest”) is the only published guide to all active clinical trials for mesothelioma. The Meso Digest is authored and updated 4 times a year by medical professionals who have decades of experience in the treatment and care of mesothelioma patients.
MesoLawyersCare is proud to make the Meso Digest available for free both as an electronic book (“eBook”) or as a convenient paperback.
The Meso Digest is a must-have resource for the mesothelioma patient or caregiver. It is the only publication available to mesothelioma patients that provides user-friendly, “digest” summaries of each and every active mesothelioma clinical trial in the United States and throughout the world.
The Meso Digest gives patients and caregivers the essential information they need for all active mesothelioma clinical trials including:
1) The Name of the Clinical Trial
2) The Type of Clinical Trial
3) The Purpose of the Clinical Trial
4) The Status of the Clinical Trial
5) The Location of the Clinical Trial
6) The Contact Person and Information for the Clinical Trial.
The Meso Digest contains information about all active clinical trials for both pleural and peritoneal mesothelioma.
Participation in clinical trials is important both to give mesothelioma patients access to cutting-edge treatments and surgical procedures, but also to facilitate research that will hopefully lead to a cure for mesothelioma.
The idea for the Meso Digest came from the authors, Eleanor “Ellie” Ericson, RN and Lisa Hyde-Barrett, RN. Ellie and Lisa are mesothelioma nurses with more than 20 years of treating and caring for more than 600 mesothelioma patients at a leading mesothelioma cancer center. Ellie and Lisa feel strongly that mesothelioma patients should consider clinical trials in evaluating all of their options for mesothelioma treatment. Ellie and Lisa realized that searching for active mesothelioma clinical trials can be difficult and confusing for mesothelioma patients and their caregivers. So Ellie and Lisa, with the support of MesoLawyersCare, decided to create and publish the Meso Digest to give patients and families this much-needed resource.
To receive the current edition of the Meso Digest by eBook or paperback, simply fill out the website form on this page or call us now at 1-888-568-1177.
Mesothelioma Clinical Trial Information
Learn More About Mesothelioma
Asbestos Exposure Information
Did You Know?
Get Help from Experienced Mesothelioma Nurses
Learn more about these experienced mesothelioma nurses by watching the video below. Click here to contact a mesothelioma nurse now.
Learn More About MesoLawyersCare
Watch the video below to learn why MesoLawyersCare is the best choice to represent you and your family after a mesothelioma diagnosis.
Contact MesoLawyersCare Now
If you or a loved one has been diagnosed with mesothelioma, please contact us to see if we can help you get the compensation you deserve from the billions of dollars in asbestos trust funds available now for qualified asbestos victims. With just one call, you can put all our experience and success to work for you.
We have represented thousands of victims of mesothelioma and their families in virtually every State in the country and in decades of work have recovered billions of dollars in financial compensation for our clients.
Call us now at 1-888-568-1177, fill out the form on this page or chat with a live person. The consultation is free and it costs nothing upfront to hire the lawyers behind MesoLawyersCare. We only get paid if you collect a settlement or verdict and you will never receive a bill from us.
Receive a
FREE No Obligation
Legal Consultation Today
Important Notice: We are unable to help if:
- Diagnosis or passing was more than three years ago
- An attorney has already been retained in this matter
“You have all been so wonderful to us, so professional, and always looking out for our best interests in every way. I know it’s a job you do. However, not once did anyone ever make us feel like we did not matter.”